| Health / Medical Topics |
Activin type 2B receptor Fc fusion protein STM 434
A soluble fusion protein containing the extracellular domain of the activin receptor type 2B (ACVR2B or ActRIIB) fused to a human Fc domain, with potential antineoplastic activity. Upon intravenous administration, STM 434 selectively binds to the growth factor activin A, thereby preventing its binding to and the activation of endogenous ActRIIB. This prevents activin A/ActRIIB-mediated signaling and inhibits the proliferation of activin A-overexpressing tumor cells. Activin A, a member of the transforming growth factor beta (TGF-beta) superfamily, is overexpressed in a variety of cancers and plays a key role in promoting cancer cell proliferation, migration, and survival. (NCI Dictionary)
YOU MAY ALSO LIKE
Activin receptor type-2B (512 aa, ~58 kDa) is encoded by the human ACVR2B gene. This protein plays a role in protein kinase-dependent…
Activin receptor type-2A (513 aa, ~58 kDa) is encoded by the human ACVR2A gene. This protein is involved in signal transduction and…
Activin receptor type-1C (493 aa, ~55 kDa) is encoded by the human ACVR1C gene. This protein plays a role in both cytokine…
Activin receptor type-1B (505 aa, ~57 kDa) is encoded by the human ACVR1B gene. This protein plays a role in protein phosphorylation,…
Activin receptor type-1 (509 aa, ~57 kDa) is encoded by the human ACVR1 gene. This protein is involved in embryonic development, protein…
Disulfide-linked homo- and heterodimeric growth factors (Activin A, Activin B, Activin AB) of the TGF Family with effects on a range of…
